Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty
| Autor: | Jonathan S. Yu, Peter K. Sculco, Ajay Premkumar, Shangyi Liu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Knee arthritis
medicine.medical_specialty medicine.medical_treatment Arthroplasty Replacement Hip Knee replacement 03 medical and health sciences 0302 clinical medicine Hip replacement Surveys and Questionnaires medicine Cannabidiol Humans In patient Postoperative Period Arthroplasty Replacement Knee 030304 developmental biology 0303 health sciences business.industry General Medicine Perioperative medicine.disease Arthroplasty digestive system diseases Surgery surgical procedures operative Orthopedic surgery business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Pain management. 11(6) |
| ISSN: | 1758-1877 |
| Popis: | Aim: To evaluate the prevalence of self-directed cannabidiol (CBD) use in patients with end-stage degenerative hip and knee arthritis who underwent total hip arthroplasty and total knee arthroplasty. Materials & methods: Anonymous surveys for 109 patients were completed at 6 weeks follow-up after either total hip arthroplasty or total knee arthroplasty at a single tertiary care US orthopedic hospital. Results: Within the perioperative window encompassing both preoperative and postoperative periods, 22% (95% CI: 14–30%) of patients used CBD. Conclusion: There was no difference in pain satisfaction between patients who used CBD and patients who did not. Given high rates of self-directed perioperative CBD use and the mixed body of evidence, further research is needed to better understand whether CBD is safe and effective. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|